Related Experiment Video
Updated: May 17, 2026

08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
DIRAE study: seasonal allergic rhinitis distribution in Spain
Allergologia Et Immunopathologia
|November 13, 2012
Summary
Patients with seasonal allergic rhinitis (SAR) receive similar care from primary care physicians and allergists. However, less than half of SAR patients achieve controlled rhinitis symptoms, regardless of physician specialty.
Area of Science:
- Allergy and Immunology
- Epidemiology
- Primary Care Medicine
Background:
- Seasonal allergic rhinitis (SAR) is a common condition impacting quality of life.
- Understanding care variations between primary care physicians (GPs) and allergists (ALs) is crucial for optimizing patient outcomes.
Purpose of the Study:
- To investigate differences in the management and outcomes of pollinic SAR patients treated by GPs versus ALs.
- To assess rhinitis severity, treatment patterns, and symptom control based on physician specialty.
Main Methods:
- A national epidemiological study involving 758 GP-recruited and 739 AL-recruited adult patients with SAR.
- Physician questionnaires collected ARIA classification, treatment, and asthma incidence data.
- Patient-reported rhinitis severity via visual analogical scale (VAS) and rhinitis control assessments.
Main Results:
- No significant differences in ARIA classification or rhinitis severity were observed between GP and AL patient groups.
- Oral antihistamines were the most common treatment (92.3% GPs, 89.3% ALs).
- Nasal corticosteroid use was higher with GPs (76.7%) than ALs (60.4%), while immunotherapy was more frequent with ALs (31.9%).
- Asthma prevalence was linked to rhinitis persistence and severity.
Conclusions:
- Patients with pollinic SAR exhibit comparable rhinitis severity regardless of whether they are managed by GPs or ALs.
- A significant proportion of SAR patients, less than half, experience controlled rhinitis symptoms, indicating a need for improved management strategies.
Related Concept Videos
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
